News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2024
June 2024
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Amol Akhade: Everolimus vs Alpelisib vs Capivasertib
Photo taken from Amol Akhade/X
Jun 13, 2024, 03:19

Amol Akhade: Everolimus vs Alpelisib vs Capivasertib

Amol Akhade, Consultant Medical Oncologist atSuyog Cancer Clinics, shared a post on X:

“Everolimus vs Alpelisib vs Capivasertib.

Even though PFS HR are similar for all 3 drugs, only capivasertib has phase III data in patients with cdk4- 6 exposure.

Toxicity profile for capivasertib is better as compared to alpelisib, especially for rash and hyperglycaemia.”

Amol Akhade

Source: Amol Akhade/X

alpelisib Amol Akhade cancer Capivasertib cdk4- 6 exposure everolimus hyperglycaemia OncoDaily Oncology Suyog Cancer Clinics
Insight
Jun 25, 2024, 10:29
Patricia LoRusso will participate in a Clinical Trials Forum at The White House on June 26 - Yale Cancer Center
Blog
Jun 25, 2024, 10:13
Rick Scott: As a Governer I’ve fought hard to make Florida a leader in cancer treatment and research
Blog
Jun 25, 2024, 09:53
Janine Austin Clayton: Celebrate National Women’s Health Week
Insight
Jun 25, 2024, 09:36
Activating molecular target reverses multiple hallmarks of aging - MD Anderson Cancer Center
Blog
Jun 25, 2024, 09:11
Sachin Jain: I’ve seen firsthand the impact of loneliness on health
Blog
Jun 25, 2024, 08:55
Wafik S. El-Deiry: Looking forward to visiting the University of Hawai'i Cancer Center in Honolulu
Blog
Jun 25, 2024, 08:35
Allison J. Applebaum: Amanda Kastrinos is a brilliant new investigator in caregiving science
Blog
Jun 25, 2024, 08:30
ASH - 2024 ASH Honorific Award recipients
Blog
Jun 25, 2024, 08:21
Global MPNSF - The EHA Congress 2024 has been a resounding success
Blog
Jun 25, 2024, 08:12
Concerning rise in colorectal cancer cases in Sub-Saharan Africa
Blog
Jun 25, 2024, 08:04
Mitchell Machiela: Findings from Genomic investigation of Chernobyl thyroid cancer cases
Blog
Jun 25, 2024, 07:47
Mark Lewis: It is UNACCEPTABLE to treat mCRC without knowing these biomarker